More on MNKD
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.10 |
|
|||
| Open | $3.10 | ||||
| 52 Wk High | $2.51 | ||||
| 52 Wk Low | $0.41 | ||||
| Day High | $3.13 | ||||
| Day Low | $3.04 | ||||
| P/E | N/A | ||||
| EPS | $-0.64 | ||||
| Volume | 2,798,774 | ||||
- Chardan Starts MannKind (MNKD) at Buy
- MannKind to Participate in the Chardan Healthcare Conference
- MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)
- MannKind (MNKD) PT Lowered to $5 at Truist Securities
- Form 4 MANNKIND CORP For: Sep 25 Filed by: Binder Steven B.
- Form 144 MANNKIND CORP Filed by: Binder Steven B.
- Form 4 MANNKIND CORP For: Sep 10 Filed by: Binder Steven B.
- MannKind (MNKD) Reiterated at Overweight by Cantor Fitzgerald on Positive MNKD-201 Ph1 Data
- MannKind (MNKD) Reiterated at Overweight by Cantor Fitzgerald on Positive MNKD-201 Ph1 Data
- Form 144 MANNKIND CORP Filed by: Binder Steven B.
Entities mentioned with MNKD
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- Pre Market Movers | View Related Stories »
- H.C. Wainwright | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
